National expenditure for false-positive mammograms and breast cancer overdiagnoses estimated at $ 4 billion a year

Health Affairs

Volumn 34, Issue 4, 2015, Pages 576-583

  Ong, Mei Sing ^a,b   Mandl, Kenneth D ^a,c  

^a BOSTON CHILDREN S HOSPITAL   (United States)

^b MACQUARIE UNIVERSITY   (Australia)

^c HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; BREAST CANCER; CANCER DIAGNOSIS; CANCER SCREENING; COST EFFECTIVENESS ANALYSIS; FALSE POSITIVE RESULT; FEMALE; GROUPS BY AGE; HEALTH CARE COST; HEALTH INSURANCE; HUMAN; INTRADUCTAL CARCINOMA; INVASIVE CARCINOMA; MAJOR CLINICAL STUDY; MAMMOGRAPHY; MIDDLE AGED; BREAST NEOPLASMS; EARLY CANCER DIAGNOSIS; ECONOMICS; HEALTH SERVICE; MASS SCREENING; RETROSPECTIVE STUDY; STATISTICS AND NUMERICAL DATA; UNITED STATES;

ADULT; BREAST NEOPLASMS; EARLY DETECTION OF CANCER; FALSE POSITIVE REACTIONS; FEMALE; HEALTH EXPENDITURES; HUMANS; MAMMOGRAPHY; MASS SCREENING; MEDICAL OVERUSE; MIDDLE AGED; RETROSPECTIVE STUDIES; UNITED STATES;

EID: 84929613843     PISSN: 02782715     EISSN: 15445208     Source Type: Journal    
DOI: 10.1377/hlthaff.2014.1087     Document Type: Article

References (37)

1. Berry DA, Cronin KA, Plevritis SK, Fryback DG, Clarke L, Zelen M, et al. Effect of screening and adjuvant therapy on mortality from breast cancer. N Engl J Med. 2005;353(17):1784-92.
2. Bleyer A, Welch HG. Effect of three decades of screening mammography on breast-cancer incidence. N Engl J Med. 2012;367(21):1998-2005.
3. Welch HG, Black WC. Overdiagnosis in cancer. J Natl Cancer Inst. 2010; 102(9):605-13.
4. Miller AB, Wall C, Baines CJ, Sun P, To T, Narod SA. Twenty five year follow-up for breast cancer incidence and mortality of the Canadian National Breast Screening Study:randomised screening trial. BMJ. 2014;348:g366.
5. Welch HG, Passow HJ. Quantifying the benefits and harms of screening mammography. JAMA Intern Med. 2014;174(3):448-54.
6. Mandelblatt JS, Cronin KA, Bailey S, Berry DA, de Koning HJ, Draisma G, et al. Effects of mammography screening under different screening schedules: model estimates of potential benefits and harms. Ann Intern Med. 2009;151(10):738-47.
7. Elmore JG, Barton MB, Moceri VM, Polk S, Arena PJ, Fletcher SW. Tenyear risk of false positive screening mammograms and clinical breast examinations. N Eng J Med. 1998; 338(16):1089-96.
8. Brown ML, Houn F, Sickles EA, Kessler LG. Screening mammography in community practice: positive predictive value of abnormal findings and yield of follow-up diagnostic procedures. AJR Am J Roentgenol. 1995;165(6):1373-7.
9. Hubbard RA, Kerlikowske K, Flowers CL, Yankaskas BC, Zhu W, Miglioretti DL. Cumulative probability of false-positive recall or biopsy recommendation after 10 years of screening mammography: a cohort study. Ann Intern Med. 2011;155(8):481-92.
10. Christiansen CL, Wang F, Barton MB, Kreuter W, Elmore JG, Gelfand AE, et al. Predicting the cumulative risk of false-positive mammograms. J Natl Cancer Inst. 2000;92(20):1657-66.
11. Gross CP, Long JB, Ross JS, Abu-Khalaf MM, Wang R, Killelea BK, et al. The cost of breast cancer screening in the Medicare population. JAMA Intern Med. 2013;173(3):220-6.
12. Lee DW, Stang PE, Goldberg GA, Haberman M. Resource use and cost of diagnostic workup of women with suspected breast cancer. Breast J. 2009;15(1):85-92.
13. Mandelblatt J, Saha S, Teutsch S, Hoerger T, Siu AL, Atkins D, et al. The cost-effectiveness of screening mammography beyond age 65 years:a systematic review for the U.S. Preventive Services Task Force. Ann Intern Med. 2003;139(10):835-42.
14. O'Donoghue C, Eklund M, Ozanne EM, Esserman LJ. Aggregate cost of mammography screening in the United States: comparison of current practice and advocated guidelines. Ann Intern Med. 2014;160(3):145.
15. Vera-Llonch M, Weycker D, Glass A, Gao S, Barker R, Qin A, et al. Healthcare costs in women with metastatic cancer receiving chemotherapy as their principal treatment modality. BMC Cancer. 2011;11:250.
16. Armstrong K, Moye E, Williams S, Berlin JA, Reynolds EE. Screening mammography in women 40 to 49 years of age: a systematic review for the American College of Physicians. Ann Intern Med. 2007; 146(7):516-26.
17. Carney PA, Miglioretti DL, Yankaskas BC, Kerlikowske K, Rosenberg R, Rutter CM, et al. Individual and combined effects of age, breast density, and hormone replacement therapy use on the accuracy of screening mammography. Ann Intern Med. 2003;138(3):168-75.
18. U.S. Preventive Services Task Force. Screening for breast cancer: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med. 2009;151(10):716-26.
19. Smith RA, Manassaram-Baptiste D, Brooks D, Cokkinides V, Doroshenk M, Saslow D, et al. Cancer screening in the United States, 2014: a review of current American Cancer Society guidelines and current issues in cancer screening. CA Cancer J Clin. 2014;64(1):30-51.
20. Nattinger AB, Laud PW, Bajorunaite R, Sparapani RA, Freeman JL. An algorithm for the use of Medicare claims data to identify women with incident breast cancer. Health Serv Res. 2004;39(6 Pt 1):1733-50.
21. To access the Appendix, click on the Appendix link in the box to the right of the article online.
22. National Center for Health Statistics. Health, United States, 2013: with special feature on prescription drugs [Internet]. Hyattsville (MD): NCHS; 2014 [cited 2015 Feb 19] p. 263. Available from: http://www.cdc.gov/ nchs/data/hus/hus13.pdf
23. Leonard GD, Swain SM. Ductal carcinoma in situ, complexities and changes. J Natl Cancer Inst. 2004; 96(12):906-20.
24. Ernster VL, Ballard-Barbash R, Barlow WE, Zheng Y, Weaver DL, Cutter G, et al. Detection of ductal carcinoma in situ in women undergoing screening mammography. J Natl Cancer Inst. 2002;94(20):1546-54.
25. Census Bureau. American Fact-Finder: annual estimates of the resident population for selected age groups by sex for the United States, states, counties, and Puerto Rico commonwealth and municipios:April 1, 2010 to July 1, 2013. Washington (DC): Census Bureau; 2014 Jun.
26. National Cancer Institute. Breast Cancer Surveillance Consortium [Internet]. Bethesda (MD): NCI; [last updated 2013 Sep 23; cited 2015 Feb 19]. Available from: http:// breastscreening.cancer.gov/ statistics/performance/screening/2009/rate_age.html
27. Siziopikou KP. Ductal carcinoma in situ of the breast: current concepts and future directions. Arch Pathol Lab Med. 2013;137(4):462-6.
28. Esserman LJ, Thompson IM, Reid B, Nelson P, Ransohoff DF, Welch HG, et al. Addressing overdiagnosis and overtreatment in cancer: a prescription for change. Lancet Oncol. 2014; 15(6):e234-42.
29. CMS.gov. Physician fee schedule search [Internet]. Baltimore (MD):Centers for Medicare and Medicaid Services; [cited 2015 Feb 24]. (Click "Accept" to view results). Available from: http://www.cms.gov/apps/ physician-fee-schedule/search/ search-results.aspx?Y=0&T=0&HT=0&CT=3&H1=19100&M=5
30. Gutwein LG, Ang DN, Liu H, Marshall JK, Hochwald SN, Copeland EM, et al. Utilization of minimally invasive breast biopsy for the evaluation of suspicious breast lesions. Am J Surg. 2011;202(2):127-32.
31. Ewertz M, Jensen AB. Late effects of breast cancer treatment and potentials for rehabilitation. Acta Oncol. 2011;50(2):187-93.
32. Schairer C, Brown LM, Chen BE, Howard R, Lynch CF, Hall P, et al. Suicide after breast cancer: an international population-based study of 723,810 women. J Natl Cancer Inst. 2006;98(19):1416-9.
33. Brodersen J, Siersma VD. Long-term psychosocial consequences of falsepositive screening mammography. Ann Fam Med. 2013;11(2):106-15.
34. Brewer NT, Salz T, Lillie SE. Systematic review: the long-term effects of false-positive mammograms. Ann Intern Med. 2007;146(7):502-10.
35. Harris R. Screening is only part of the answer to breast cancer. Ann Intern Med. 2014;160(12):861-3.
36. Schousboe JT, Kerlikowske K, Loh A, Cummings SR. Personalizing mammography by breast density and other risk factors for breast cancer:analysis of health benefits and costeffectiveness. Ann Intern Med. 2011;155(1):10-20.
37. Mandelson MT, Oestreicher N, Porter PL, White D, Finder CA, Taplin SH, et al. Breast density as a predictor of mammographic detection:comparison of interval- and screen-detected cancers. J Natl Cancer Inst. 2000;92(13):1081-7.